Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 29, Issue 3, 2016, Pages 523-533

  Li, Yan ^a   Jakary, Angela ^a   Gillung, Erin ^b   Eisendrath, Stuart ^b   Nelson, Sarah J ^a,b   Mukherjee, Pratik ^a   Luks, Tracy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

7 Tesla; Magnetic resonance spectroscopic imaging; Major depressive disorder; MBCT

Indexed keywords

ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ANALOGS AND DERIVATIVES; BRAIN CORTEX; CASE CONTROL STUDY; CAUDATE NUCLEUS; CINGULATE GYRUS; COGNITIVE BEHAVIORAL THERAPY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MINDFULNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PUTAMEN; THALAMUS; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ASPARTIC ACID; CASE-CONTROL STUDIES; CAUDATE NUCLEUS; CEREBRAL CORTEX; COGNITIVE BEHAVIORAL THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MINDFULNESS; PUTAMEN; THALAMUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84957709154     PISSN: 09685243     EISSN: 13528661     Source Type: Journal    
DOI: 10.1007/s10334-016-0526-7     Document Type: Article

References (43)

1. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA (2000) Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 68(4):615–623
2. Ma SH, Teasdale JD (2004) Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 72(1):31–40
3. Finucane A, Mercer SW (2006) An exploratory mixed methods study of the acceptability and effectiveness of mindfulness-based cognitive therapy for patients with active depression and anxiety in primary care. BMC Psychiatry 6:14
4. Barnhofer T, Crane C, Hargus E, Amarasinghe M, Winder R, Williams JM (2009) Mindfulness-based cognitive therapy as a treatment for chronic depression: a preliminary study. Behav Res Ther 47(5):366–373
5. Eisendrath SJ, Delucchi K, Bitner R, Fenimore P, Smit M, McLane M (2008) Mindfulness-based cognitive therapy for treatment-resistant depression: a pilot study. Psychother Psychosom 77(5):319–320
6. Tkac I, Oz G, Adriany G, Ugurbil K, Gruetter R (2009) In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn Reson Med 62(4):868–879
7. Choi C, Douglas D, Hawesa H, Jindal A, Storey C, Dimitrov I (2009) Measurement of glycine in human prefrontal brain by point-resolved spectroscopy at 7.0 tesla in vivo. Magn Reson Med 62(5):1305–1310
8. Mekle R, Mlynarik V, Gambarota G, Hergt M, Krueger G, Gruetter R (2009) MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn Reson Med 61(6):1279–1285
9. An L, Li S, Wood ET, Reich DS, Shen J (2014) N-acetyl-aspartyl-glutamate detection in the human brain at 7 Tesla by echo time optimization and improved Wiener filtering. Magn Reson Med 72(4):903–912
10. Yildiz-Yesiloglu A, Ankerst DP (2006) Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 147(1):1–25
11. Caverzasi E, Pichiecchio A, Poloni GU, Calligaro A, Pasin M, Palesi F, Castellazzi G, Pasquini M, Biondi M, Barale F, Bastianello S (2012) Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature. Funct Neurol 27(1):13–22
12. Eisendrath SJ, Gillung E, Delucchi K, Mathalon DH, Yang TT, Satre DD, Rosser R, Sipe WEB, Wolkowitz OM (2015) A preliminary study: efficacy of mindfulness-based cognitive therapy versus sertraline as first-line treatments for major depressive disorder. Mindfulness 6(3):475–482
13. Segal Z, Williams JM, Teasdale JD (2002) Mindfulness-based cognitive therapy for depression: a new approach to preventing replase. The Guilford press, New York
14. Eisendrath SJ, Gillung EP, Delucchi KL, Chartier M, Mathalon DH, Sullivan JC, Segal ZV, Feldman MD (2014) Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol. BMC Complement Altern Med 14:95
15. Li Y, Larson P, Chen AP, Lupo JM, Ozhinsky E, Kelley D, Chang SM, Nelson SJ (2015) Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 tesla for characterization of differences in metabolite levels. J Magn Reson Imaging 41(5):1332–1341
16. Cunningham CH, Vigneron DB, Chen AP, Xu D, Nelson SJ, Hurd RE, Kelley DA, Pauly JM (2005) Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging. Magn Reson Med 54(5):1286–1289
17. Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30(6):672–679
18. Graveron-Demilly D, Diop A, Briguet A, Fenet B (1993) Product-operator algebra for strongly coupled spin system. J Magn Reson Ser A 101(3):233–239
19. Govindaraju V, Young K, Maudsley AA (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13(3):129–153
20. Frazier JA, Chiu S, Breeze JL, Makris N, Lange N, Kennedy DN, Herbert MR, Bent EK, Koneru VK, Dieterich ME, Hodge SM, Rauch SL, Grant PE, Cohen BM, Seidman LJ, Caviness VS, Biederman J (2005) Structural brain magnetic resonance imaging of limbic and thalamic volumes in pediatric bipolar disorder. Am J Psychiatry 162(7):1256–1265
21. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31(3):968–980
22. Otazo R, Mueller B, Ugurbil K, Wald L, Posse S (2006) Signal-to-noise ratio and spectral linewidth improvements between 1.5 and 7 Tesla in proton echo-planar spectroscopic imaging. Magn Reson Med 56(6):1200–1210
23. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Payne M, Moore D (1994) Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 18(7):1121–1127
24. Vythilingam M, Charles HC, Tupler LA, Blitchington T, Kelly L, Krishnan KR (2003) Focal and lateralized subcortical abnormalities in unipolar major depressive disorder: an automated multivoxel proton magnetic resonance spectroscopy study. Biol Psychiatry 54(7):744–750
25. Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M (1999) Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. Am J Psychiatry 156(10):1638–1640
26. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Res 67(2–3):269–275
27. Hamidi M, Drevets WC, Price JL (2004) Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 55(6):563–569
28. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47(4):305–313
29. Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS (2005) Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry 57(12):1526–1534
30. Chen LP, Dai HY, Dai ZZ, Xu CT, Wu RH (2014) Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: a 1H magnetic resonance spectroscopy study. Psychiatry Clin Neurosci 68(5):357–364
31. Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S (2006) The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 30(1):120–125
32. Ongur D, Drevets WC, Price JL (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 95(22):13290–13295
33. Rajkowska G (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48(8):766–777
34. Gruber S, Frey R, Mlynarik V, Stadlbauer A, Heiden A, Kasper S, Kemp GJ, Moser E (2003) Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol 38(7):403–408
35. Craig AD (2009) How do you feel–now? The anterior insula and human awareness. Nat Rev Neurosci 10(1):59–70
36. Avery JA, Drevets WC, Moseman SE, Bodurka J, Barcalow JC, Simmons WK (2014) Major depressive disorder is associated with abnormal interoceptive activity and functional connectivity in the insula. Biol Psychiatry 76(3):258–266
37. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B (2003) Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 33(7):1277–1284
38. Luborzewski A, Schubert F, Seifert F, Danker-Hopfe H, Brakemeier EL, Schlattmann P, Anghelescu I, Colla M, Bajbouj M (2007) Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 41(7):606–615
39. Lagopoulos J, Hermens DF, Tobias-Webb J, Duffy S, Naismith SL, White D, Scott E, Hickie IB (2013) In vivo glutathione levels in young persons with bipolar disorder: a magnetic resonance spectroscopy study. J Psychiatr Res 47(3):412–417
40. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56(11):1043–1047
41. Sanacora G, Mason GF, Rothman DL, Krystal JH (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159(4):663–665
42. Rajkowska G, O’Dwyer G, Teleki Z, Stockmeier CA, Miguel-Hidalgo JJ (2007) GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32(2):471–482
43. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, Boorman E, Matthews PM, Cowen PJ (2008) Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 11(2):255–260